| Jeffrey Donovan Weaver, MD | |
|
1 Saint Joseph Dr, Lexington, KY 40504-3742 | |
| (859) 313-1000 | |
| Not Available |
| Full Name | Jeffrey Donovan Weaver |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1 Saint Joseph Dr, Lexington, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083660930 | NPI | - | NPPES |
| 64109937 | Medicaid | KY | |
| P00329507 | Other | KY | RRGA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 40475 (Kentucky) | Primary |
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
The brain responses of those children who don't get enough sleep can accurately predict the impact sleep loss has on their ability to pay attention during the course of a day, according to a research abstract presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
Patients with diarrhea-predominant irritable bowel syndrome, or IBS-D, treated with eluxadoline achieved better clinical response and experienced more symptom improvement than those using placebo, according to a recent study in Gastroenterology, the official journal of the American Gastroenterological Association. Eluxadoline, which is currently in phase 3 trials, is under development as a potential treatment for IBS-D.
Groundbreaking ceremonies on December 15 will mark the launch of a unique project that exemplifies how new technologies are being used to address a key healthcare reform issue: the multi-billion dollar cost of repeatedly hospitalizing patients with chronic conditions such as diabetes, high blood pressure, heart failure, asthma and lung disease.
Repros Therapeutics today announced the pricing of its public offering of 690,000 units, consisting of 2,760,000 shares of its common stock, Series A Warrants to purchase 2,070,000 shares of common stock and Series B Warrants to purchase 1,690,500 shares of its common stock, at a price per unit of $17.15.
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.
› Verified 3 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
The brain responses of those children who don't get enough sleep can accurately predict the impact sleep loss has on their ability to pay attention during the course of a day, according to a research abstract presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
Patients with diarrhea-predominant irritable bowel syndrome, or IBS-D, treated with eluxadoline achieved better clinical response and experienced more symptom improvement than those using placebo, according to a recent study in Gastroenterology, the official journal of the American Gastroenterological Association. Eluxadoline, which is currently in phase 3 trials, is under development as a potential treatment for IBS-D.
Groundbreaking ceremonies on December 15 will mark the launch of a unique project that exemplifies how new technologies are being used to address a key healthcare reform issue: the multi-billion dollar cost of repeatedly hospitalizing patients with chronic conditions such as diabetes, high blood pressure, heart failure, asthma and lung disease.
Repros Therapeutics today announced the pricing of its public offering of 690,000 units, consisting of 2,760,000 shares of its common stock, Series A Warrants to purchase 2,070,000 shares of common stock and Series B Warrants to purchase 1,690,500 shares of its common stock, at a price per unit of $17.15.
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Donovan Weaver, MD 255 S Ashland Ave, Lexington, KY 40502-1727 Ph: (859) 312-2029 | Jeffrey Donovan Weaver, MD 1 Saint Joseph Dr, Lexington, KY 40504-3742 Ph: (859) 313-1000 |
News Archive
The brain responses of those children who don't get enough sleep can accurately predict the impact sleep loss has on their ability to pay attention during the course of a day, according to a research abstract presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
Patients with diarrhea-predominant irritable bowel syndrome, or IBS-D, treated with eluxadoline achieved better clinical response and experienced more symptom improvement than those using placebo, according to a recent study in Gastroenterology, the official journal of the American Gastroenterological Association. Eluxadoline, which is currently in phase 3 trials, is under development as a potential treatment for IBS-D.
Groundbreaking ceremonies on December 15 will mark the launch of a unique project that exemplifies how new technologies are being used to address a key healthcare reform issue: the multi-billion dollar cost of repeatedly hospitalizing patients with chronic conditions such as diabetes, high blood pressure, heart failure, asthma and lung disease.
Repros Therapeutics today announced the pricing of its public offering of 690,000 units, consisting of 2,760,000 shares of its common stock, Series A Warrants to purchase 2,070,000 shares of common stock and Series B Warrants to purchase 1,690,500 shares of its common stock, at a price per unit of $17.15.
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and Tianjin Medical University Cancer Institute and Hospital in China have discovered that combining chemotherapy drugs and immunotherapy cancer vaccines results in an enhanced anti-tumor effect.
› Verified 3 days ago
Mikalah Andree Ward, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Rose St Rm M-53, Lexington, KY 40536 Phone: 859-323-5083 | |
Allison Woodall, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky And Affiliates, 800 Rose St., Lexington, KY 40536 Phone: 859-323-5871 | |
Traci Westerfield, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2416 Regency Road, Lexington, KY 40503 Phone: 859-278-1316 Fax: 859-276-1574 | |
Dr. Hollis R Hilty, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1740 Nicholasville Road, Lexington, KY 40503 Phone: 859-260-6180 Fax: 859-260-6693 | |
James Byron Moore Ii, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3205 Summit Square Pl Ste 100, Lexington, KY 40509 Phone: 859-335-9041 Fax: 859-335-9072 | |
Dr. Matthew Stewart Dawson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 230 W Main St, Lexington, KY 40507 Phone: 859-309-4839 | |
Dr. Jeremiah Phelps, MD PHD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky, 800 Rose St, Lexington, KY 40536 Phone: 859-323-6762 |